{
    "body": "Is the protein product of the cylindromatosis gene (CYLD) a deubiquitinating enzyme?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/21283724", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19412431", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20836156", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16900776", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18497946", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21931165", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17925880", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23066153", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17392286", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17053834", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19893491", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17765686", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18643924", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21573132", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22406061", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20227366", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17495026", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21109933", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20644164", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21728169"
    ], 
    "ideal_answer": [
        "CYLD is a tumour-suppressor gene that is mutated in a benign skin tumour syndrome called cylindromatosis. The CYLD gene product is a deubiquitinating enzyme that was shown to regulate cell proliferation, cell survival and inflammatory responses, mainly through inhibiting NF-kappaB signalling.  ", 
        "The cylindromatosis tumor suppressor (CYLD) is a deubiquitinating enzyme that has been implicated in various aspects of adaptive and innate immune responses. The deubiquitinating enzyme CYLD has been identified as a key negative regulator for NF-kappaB. ", 
        "The cylindromatosis gene (CYLD) was identified as a tumor suppressor gene, which is mutated in familial cylindromatosis, an autosomal-dominant predisposition to multiple tumors of the skin appendages. CYLD is a deubiquitinating enzyme acting as a negative regulator of the nuclear factor \u03baB (NF-\u03baB) signaling pathway by removing lysine-63-linked polyubiquitin chains from NF-\u03baB activating proteins.", 
        "Here, we identify the deubiquitinating enzyme CYLD, the familial cylindromatosis tumor suppressor gene, as a negative regulator of proximal events in Wnt/beta-catenin signaling.CYLD, a tumor suppressor gene, has deubiquitinating enzyme activity and inhibits the activation of transcription factor NF-kappaB. Loss of the deubiquitinating activity of CYLD is correlated with tumorigenesis."
    ], 
    "exact_answer": "yes", 
    "concepts": [
        "http://www.uniprot.org/uniprot/SSEL_SALTI", 
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0004843", 
        "http://www.uniprot.org/uniprot/SSEL_SALCH", 
        "http://www.uniprot.org/uniprot/CYLD_PONAB", 
        "http://www.uniprot.org/uniprot/SSEL_SALPA", 
        "http://www.uniprot.org/uniprot/SSEL_SALPB", 
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0016579"
    ], 
    "type": "yesno", 
    "id": "550aef0ec2af5d5b7000000a", 
    "snippets": [
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 365, 
            "text": "CYLD was originally identified as a tumor suppressor gene mutated in familial cylindromatosis, an autosomal dominant predisposition to multiple benign neoplasms of the skin known as cylindromas. The CYLD protein is a deubiquitinating enzyme that acts as a negative regulator of NF-\u03baB and JNK signaling through its interaction with NEMO and TNFR-associated factor 2.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23066153", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 262, 
            "text": "CYLD, a deubiquitinating enzyme (DUB), is a critical regulator of diverse cellular processes, ranging from proliferation and differentiation to inflammatory responses, via regulating multiple key signaling cascades such as nuclear factor kappa B (NF-\u03baB) pathway.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22406061", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 82, 
            "text": "CYLD is a lysine 63-deubiquitinating enzyme that inhibits NF-\u03baB and JNK signaling.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21931165", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 197, 
            "text": "Tumor suppressor gene CYLD is a deubiquitinating enzyme which negatively regulates various signaling pathways by removing the lysine 63-linked polyubiquitin chains from several specific substrates.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21573132", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 158, 
            "text": "The cylindromatosis tumor suppressor (CYLD) is a deubiquitinating enzyme that has been implicated in various aspects of adaptive and innate immune responses. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21283724", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 426, 
            "text": "The cylindromatosis gene (CYLD) was identified as a tumor suppressor gene, which is mutated in familial cylindromatosis (Brooke-Spiegler syndrome), an autosomal-dominant predisposition to multiple tumors of the skin appendages. CYLD is a deubiquitinating enzyme acting as a negative regulator of the nuclear factor \u03baB (NF-\u03baB) signaling pathway by removing lysine-63-linked polyubiquitin chains from NF-\u03baB activating proteins. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21109933", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 293, 
            "offsetInEndSection": 470, 
            "text": "Here, we identify the deubiquitinating enzyme CYLD, the familial cylindromatosis tumor suppressor gene, as a negative regulator of proximal events in Wnt/beta-catenin signaling.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20227366", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 293, 
            "text": "CYLD is a tumour-suppressor gene that is mutated in a benign skin tumour syndrome called cylindromatosis. The CYLD gene product is a deubiquitinating enzyme that was shown to regulate cell proliferation, cell survival and inflammatory responses, mainly through inhibiting NF-kappaB signalling.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19893491", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 163, 
            "text": "Cyld encodes a 956-amino acid deubiquitinating enzyme (CYLD), which is a negative regulator of nuclear factor kappaB and mitogen-activated protein kinase pathways.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19412431", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 402, 
            "offsetInEndSection": 498, 
            "text": "The deubiquitinating enzyme CYLD has been identified as a key negative regulator for NF-kappaB. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18643924", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 214, 
            "offsetInEndSection": 424, 
            "text": "CYLD, a tumor suppressor gene, has deubiquitinating enzyme activity and inhibits the activation of transcription factor NF-kappaB. Loss of the deubiquitinating activity of CYLD is correlated with tumorigenesis.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18497946", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 645, 
            "offsetInEndSection": 794, 
            "text": "We show that dCYLD encodes a deubiquitinating enzyme that deubiquitinates dTRAF2 and prevents dTRAF2 from ubiquitin-mediated proteolytic degradation.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17765686", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 113, 
            "offsetInEndSection": 298, 
            "text": "The CYLD gene encodes a deubiquitinating enzyme that removes Lys-63-linked ubiquitin chains from I kappa B kinase signaling components and thereby inhibits NF-kappaB pathway activation.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17495026", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 415, 
            "text": "Deubiquitinating enzymes (DUB) form a family of cysteine proteases that digests ubiquitin chains and reverses the process of protein ubiquitination. Despite the identification of a large number of DUBs, their physiological functions remain poorly defined. Here we provide genetic evidence that CYLD, a recently identified DUB, plays a crucial role in regulating the peripheral development and activation of B cells.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17392286", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 398, 
            "text": "The cylindromatosis (CYLD) gene was originally identified as a tumor suppressor that is mutated in familial cylindromatosis, an autosomal dominant condition that confers a predisposition to multiple tumors of the skin appendages. CYLD has deubiquitinating enzyme activity and inhibits the activation of transcription factor NF-kappaB. Therefore, loss of CYLD function correlates with tumorigenesis.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16900776", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 180, 
            "text": "Cylindromatosis gene (CYLD) is a ubiquitously expressed deubiquitinating enzyme, which interacts with members of the NF-\u03baB signaling pathway and attenuates NF-\u03baB and JNK signaling.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20836156", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 121, 
            "text": "The cylindromatosis tumor suppressor gene (Cyld) encodes a deubiquitinating enzyme (CYLD) with immunoregulatory function.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20644164", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 104, 
            "offsetInEndSection": 292, 
            "text": "The CYLD gene product is a deubiquitinating enzyme that was shown to regulate cell proliferation, cell survival and inflammatory responses, mainly through inhibiting NF-kappaB signalling.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19893491", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 124, 
            "offsetInEndSection": 287, 
            "text": "Here, we examined the potential role of the deubiquitinating enzyme CYLD (cylindromatosis), mutation of which has been reported to cause familial cylindromatosis.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18245814", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 311, 
            "offsetInEndSection": 530, 
            "text": "The deubiquitinating enzyme cylindromatosis (CYLD), loss of which was originally reported to cause a benign human syndrome called cylindromatosis, has been identified as a key negative regulator for NF-kappaB in vitro.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17925880", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 106, 
            "offsetInEndSection": 293, 
            "text": "The CYLD gene product is a deubiquitinating enzyme that was shown to regulate cell proliferation, cell survival and inflammatory responses, mainly through inhibiting NF-kappaB signalling.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19893491", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 180, 
            "text": "Cylindromatosis gene (CYLD) is a ubiquitously expressed deubiquitinating enzyme, which interacts with members of the NF-\ufffdB signaling pathway and attenuates NF-\ufffdB and JNK signaling.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20836156", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 171, 
            "text": "Cylindromatosis (CYLD) is a deubiquitinating enzyme that is altered in patients with familial cylindromatosis, a condition characterized by numerous benign adnexal tumors.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17053834", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 104, 
            "text": "CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/12917689", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 292, 
            "offsetInEndSection": 468, 
            "text": "Here, we identify the deubiquitinating enzyme CYLD, the familial cylindromatosis tumor suppressor gene, as a negative regulator of proximal events in Wnt/beta-catenin signaling", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20227366", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 180, 
            "text": "Cylindromatosis gene (CYLD) is a ubiquitously expressed deubiquitinating enzyme, which interacts with members of the NF-\u03baB signaling pathway and attenuates NF-\u03baB and JNK signaling", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20836156", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 106, 
            "offsetInEndSection": 292, 
            "text": "The CYLD gene product is a deubiquitinating enzyme that was shown to regulate cell proliferation, cell survival and inflammatory responses, mainly through inhibiting NF-kappaB signalling", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19893491", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 120, 
            "text": "The cylindromatosis tumor suppressor gene (Cyld) encodes a deubiquitinating enzyme (CYLD) with immunoregulatory function", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20644164", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 179, 
            "text": "Cylindromatosis gene (CYLD) is a ubiquitously expressed deubiquitinating enzyme, which interacts with members of the NF-\u03baB signaling pathway and attenuates NF-\u03baB and JNK signaling", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20836156", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 226, 
            "text": "The cylindromatosis tumor suppressor gene (Cyld) encodes an enzyme (CYLD) with deubiquitinating activity that has been implicated in the regulation of thymocyte selection in an NF-\u03baB-essential-modulator (NEMO)-dependent manner", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21728169", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 293, 
            "offsetInEndSection": 469, 
            "text": "Here, we identify the deubiquitinating enzyme CYLD, the familial cylindromatosis tumor suppressor gene, as a negative regulator of proximal events in Wnt/beta-catenin signaling", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20227366", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 228, 
            "offsetInEndSection": 424, 
            "text": "CYLD is a deubiquitinating enzyme acting as a negative regulator of the nuclear factor \u03baB (NF-\u03baB) signaling pathway by removing lysine-63-linked polyubiquitin chains from NF-\u03baB activating proteins", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21109933", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 214, 
            "offsetInEndSection": 343, 
            "text": "CYLD, a tumor suppressor gene, has deubiquitinating enzyme activity and inhibits the activation of transcription factor NF-kappaB", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18497946", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 126, 
            "offsetInEndSection": 287, 
            "text": "Here, we examined the potential role of the deubiquitinating enzyme CYLD (cylindromatosis), mutation of which has been reported to cause familial cylindromatosis", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18245814", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 230, 
            "offsetInEndSection": 333, 
            "text": "CYLD has deubiquitinating enzyme activity and inhibits the activation of transcription factor NF-kappaB", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16900776", 
            "endSection": "abstract"
        }
    ]
}